PVLA insider sales reported under Rule 144

PVLA reports Rule 144 sales of Common Stock by an insider and a planned sale under a stock option.

Rhea-AI Filing Summary

PVLA reports Rule 144 sales of Common Stock by an insider and a planned sale under a stock option. The filing lists a planned sale dated 03/18/2026 described as Stock Option for Common stock to be sold for cash.

The filing also discloses prior reported dispositions by Kathleen Goin: 415,022 on 12/17/2025, 419,983 on 01/21/2026, and 341,563 on 02/18/2026. The transactions list NASDAQ as the market.

Insights

Securities Compliance Counsel

Rule 144 notices for PVLA list a scheduled stock-option sale and multiple prior dispositions by a reporting person.

The filing records a planned sale dated 03/18/2026 described as a Stock Option sale for cash, plus three earlier reported dispositions by Kathleen Goin on 12/17/2025, 01/21/2026, and 02/18/2026.

These notices are procedural compliance documents under Rule 144; cash‑flow treatment and proceeds recipients are stated as cash for the planned sale, and timing is explicit in the listed dates.

Insider Transactions Analyst

Multiple small-to-midsize dispositions are reported; the pattern is routine reporting of insider sales.

The excerpt provides exact disposition figures of 415,022, 419,983, and 341,563 tied to specific dates, and an intended option-based sale on 03/18/2026. The filing names NASDAQ as the trading market.

Disclosure here documents transfers under Rule 144; further filings would be needed to trace cash amounts or remaining holdings.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does PVLA's Form 144 say about upcoming sales?

The Form 144 lists a planned sale under a Stock Option dated 03/18/2026, with the sale method described as for cash. It identifies the security as Common stock and lists NASDAQ as the market.

Who reported prior dispositions in PVLA's filing?

Kathleen Goin is named with reported dispositions of 415,022 on 12/17/2025, 419,983 on 01/21/2026, and 341,563 on 02/18/2026, as shown in the excerpt.

Do the filings state how proceeds are handled for PVLA sales?

The planned sale dated 03/18/2026 is described as a sale for cash. The excerpt does not provide dollar proceeds figures or recipient breakdowns beyond that label.

On which market were PVLA securities listed in the filing?

The excerpt identifies NASDAQ as the market for the Common stock transactions and the planned sale dated 03/18/2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/18/2026 - 04:01 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001912570
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	PALVELLA THERAPEUTICS, INC.
SEC File Number	001-37471
Address of Issuer	353 W. LANCASTER AVENUE SUITE 200 WAYNE PENNSYLVANIA 19087
Phone	(484) 253-1461
Name of Person for Whose Account the Securities are To Be Sold	Goin Kathleen
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Piper Sandler and Co 350 North 5th Street Minneapolis MN 55401	4302	519681.00	12688329	03/18/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/18/2026	Stock Option	Company			4302	03/18/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Kathleen Goin 353 W. LANCASTER AVENUE Wayne PA 19087	Common	02/18/2026	4302	341563.00
Kathleen Goin 353 W. LANCASTER AVENUE, Wayne PA 19087	Common	01/21/2026	4302	419983.00
Kathleen Goin 353 W. LANCASTER AVENUE Wayne PA 19087	Common	12/17/2025	4302	415022.00

144: Remarks and Signature

Remarks
Date of Notice	03/18/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	08/19/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Dan Schmidt, as a duly authorized representative of Piper Sandler & Co Corporate & Venture Services FA, as attorney-in-fact Kathleen Goin
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)